Last reviewed · How we verify

NCT05567432

Hemostasis in Thyroidectomy, Comparison Between Diathermy and Ligasure

Status unknown NA Last updated 5 October 2022
What this trial tests

NA trial testing thyroidectomy in Thyroid in 40 participants. Status unknown.

Timeline
1 January 2023
Primary endpoint
30 December 2023
31 December 2023

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 January 2023
Primary completion30 December 2023
Estimated completion31 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Thyroid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thyroidectomy is one of the most surgeries done by surgeons. Postoperative bleeding is a main complication for this surgery.surgeons usually do homeostasis by traditional diathermy as it is cheep and available in all hospitals and centres. Atlternatinve surgery devices have become popular to conventional hemostasis in thyroid surgery. These devices reduce operative time and post-operative complication .Investigators thought to examine relative efficiency of two alternative energy devices compared to each other in preventing post-operative complication between diathermy and ligasure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of thyroidectomy

Trials testing the same drug.

Other recruiting trials for Thyroid

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05567432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing